法国药物化学学会或“法国化学学会”(SCT)成立于1966年。自成立以来,其使命是促进药物研发主要领域的知识,特别是对具有治疗意义的生物靶标的研究和验证,筛选,候选药物的设计和优化,化学生物学,药物化学,药代动力学,代谢和毒性。自1964年以来,该协会每年组织一次国际大会(RICT),以及后来为年轻研究人员举办的主题日和关于特定主题的研讨会。SCT还是欧洲药物化学联合会(EFMC)的成员,并于2022年在尼斯组织了国际药物化学研讨会(ISMC)。SCT的活动中可以发现几个新趋势,例如组织定期的网络研讨会,还有最近成立的青年医学论坛,以及分发通讯,报道法国社区和国外的科学成就,以及在社交网络上的改进。这些趋势与当前该领域在科学进步方面的变化是一致的,社区和公众的沟通手段和包容性。
The French Society of Medicinal Chemistry or \" Société de Chimie Thérapeutique \" (SCT) was founded in 1966. Since its inception, its mission has been to promote knowledge in the main fields of pharmaceutical research and development, in particular the research and validation of biological targets of therapeutic interest, the screening, design and optimization of drug candidates, chemical biology, medicinal chemistry, pharmacokinetics, metabolism and toxicity. Since 1964, the Society has organized an annual international congress (RICT), and later thematic days for young researchers and workshops on specific topics. The SCT is also a member of the European Federation for Medicinal Chemistry (EFMC) and organized the International Symposium on Medicinal Chemistry (ISMC) in Nice in 2022. Several new trends can be identified in the activities of the SCT, such as the organization of regular webinars, but also the recent creation of the Young MedChem Forum, as well as the distribution of a newsletter reporting scientific achievements in the French community and abroad, and an improved presence on social networks. These trends are in line with the current changes in the field in terms of scientific progress, means of communication in the community and with the public and inclusiveness.